Baxter International Inc (BAX)
32.85
-0.21
(-0.64%)
USD |
NYSE |
Jul 02, 16:00
32.86
+0.01
(+0.03%)
Pre-Market: 20:00
Baxter International SG&A Expense (TTM): 3.896B for March 31, 2024
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 3.896B |
December 31, 2023 | 3.815B |
September 30, 2023 | 3.755B |
June 30, 2023 | 3.694B |
March 31, 2023 | 3.70B |
December 31, 2022 | 3.838B |
September 30, 2022 | 3.823B |
June 30, 2022 | 3.566B |
March 31, 2022 | 3.274B |
December 31, 2021 | 2.849B |
September 30, 2021 | 2.685B |
June 30, 2021 | 2.602B |
March 31, 2021 | 2.513B |
December 31, 2020 | 2.514B |
September 30, 2020 | 3.239B |
June 30, 2020 | 3.265B |
March 31, 2020 | 3.317B |
December 31, 2019 | 3.29B |
September 30, 2019 | 2.497B |
June 30, 2019 | 2.554B |
March 31, 2019 | 2.594B |
December 31, 2018 | 2.603B |
September 30, 2018 | 2.705B |
June 30, 2018 | 2.709B |
March 31, 2018 | 2.658B |
Date | Value |
---|---|
December 31, 2017 | 2.612B |
September 30, 2017 | 2.552B |
June 30, 2017 | 2.59B |
March 31, 2017 | 2.669B |
December 31, 2016 | 2.746B |
September 30, 2016 | 2.809B |
June 30, 2016 | 2.877B |
March 31, 2016 | 2.951B |
December 31, 2015 | 3.094B |
September 30, 2015 | 3.221B |
June 30, 2015 | 3.254B |
March 31, 2015 | 3.459B |
December 31, 2014 | 3.585B |
September 30, 2014 | 3.221B |
June 30, 2014 | 3.369B |
March 31, 2014 | 3.219B |
December 31, 2013 | 3.104B |
September 30, 2013 | 3.607B |
June 30, 2013 | 3.375B |
March 31, 2013 | 3.326B |
December 31, 2012 | 3.283B |
September 30, 2012 | 3.17B |
June 30, 2012 | 3.214B |
March 31, 2012 | 3.19B |
December 31, 2011 | 3.154B |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (TTM) Range, Past 5 Years
2.497B
Minimum
Sep 2019
3.896B
Maximum
Mar 2024
3.270B
Average
3.29B
Median
Dec 2019
SG&A Expense (TTM) Benchmarks
LeMaitre Vascular Inc | 74.76M |
Outset Medical Inc | 137.84M |
Abbott Laboratories | 11.15B |
Boston Scientific Corp | 5.339B |
Insulet Corp | 771.90M |